Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications

Quinolones are one of the types of antibiotics with higher resistance rates in the last years. At molecular level, quinolones block type II topoisomerases producing double strand breaks (DSBs). These DSBs could play a double role, as inductors of the quinolone bactericidal effects but also as mediat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista española de quimioterapia 2015-06, Vol.28 (3), p.139-144
Hauptverfasser: González-Soltero, Rocio, García-Cañas, Ana, Mohedano, Rosa B, Mendoza-Chamizo, Belén, Botello, Emilia
Format: Artikel
Sprache:spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 144
container_issue 3
container_start_page 139
container_title Revista española de quimioterapia
container_volume 28
creator González-Soltero, Rocio
García-Cañas, Ana
Mohedano, Rosa B
Mendoza-Chamizo, Belén
Botello, Emilia
description Quinolones are one of the types of antibiotics with higher resistance rates in the last years. At molecular level, quinolones block type II topoisomerases producing double strand breaks (DSBs). These DSBs could play a double role, as inductors of the quinolone bactericidal effects but also as mediators of the resistance and tolerance mechanisms. In this work we have studied the molecular pathways responsible for DSBs repair in the quinolone susceptibility: the stalled replication fork reversal (recombination-dependent) (RFR), the SOS response induction, the translesional DNA synthesis (TLS) and the nucleotide excision repair mechanisms (NER). For this reason, at the European University in Madrid, we analysed the minimal inhibitory concentration (MIC) to three different quinolones in Escherichia coli mutant strains coming from different type culture collections. recA, recBC, priA and lexA mutants showed a significant reduction on the MIC values for all quinolones tested. No significant changes were observed on mutant strains for TLS and NER. These data indicate that in the presence of quinolones, RFR mechanisms and the SOS response could be involved in the quinolone susceptibility.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1685760165</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1685760165</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-f1bf18032052cef81a4f99c1a0896f8294d4a1f8e0a79c23d9d916f3faddd95a3</originalsourceid><addsrcrecordid>eNo1kFtLAzEUhIMgtlb_guTRl4Vkb018K7VeoCiIPi9nc6FHs8k2yQr99y6oTzMDH8MwZ2TJpRCFbLhYkMuUPhmrq1ryC7IoW1aVUool8W_BGRos1WHqZ5dyBK_p_cuG9tHAF41mBIzUhkiPE_rggp8p4xNm_MZ8oujpLqmDiagOCFQFh3c0zxlGM2VUFIfRoYKMwacrcm7BJXP9pyvy8bB73z4V-9fH5-1mX4y85rmwvLdczBtZUypjBYfaSqk4MCFbK0pZ6xq4FYbBWqqy0lJL3trKgtZaNlCtyO1v7xjDcTIpdwMmZZwDb8KUOt6KZt0y3jYzevOHTv1gdDdGHCCeuv-Pqh-IfGPK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1685760165</pqid></control><display><type>article</type><title>Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>González-Soltero, Rocio ; García-Cañas, Ana ; Mohedano, Rosa B ; Mendoza-Chamizo, Belén ; Botello, Emilia</creator><creatorcontrib>González-Soltero, Rocio ; García-Cañas, Ana ; Mohedano, Rosa B ; Mendoza-Chamizo, Belén ; Botello, Emilia</creatorcontrib><description>Quinolones are one of the types of antibiotics with higher resistance rates in the last years. At molecular level, quinolones block type II topoisomerases producing double strand breaks (DSBs). These DSBs could play a double role, as inductors of the quinolone bactericidal effects but also as mediators of the resistance and tolerance mechanisms. In this work we have studied the molecular pathways responsible for DSBs repair in the quinolone susceptibility: the stalled replication fork reversal (recombination-dependent) (RFR), the SOS response induction, the translesional DNA synthesis (TLS) and the nucleotide excision repair mechanisms (NER). For this reason, at the European University in Madrid, we analysed the minimal inhibitory concentration (MIC) to three different quinolones in Escherichia coli mutant strains coming from different type culture collections. recA, recBC, priA and lexA mutants showed a significant reduction on the MIC values for all quinolones tested. No significant changes were observed on mutant strains for TLS and NER. These data indicate that in the presence of quinolones, RFR mechanisms and the SOS response could be involved in the quinolone susceptibility.</description><identifier>EISSN: 1988-9518</identifier><identifier>PMID: 26032998</identifier><language>spa</language><publisher>Spain</publisher><subject>Anti-Bacterial Agents - pharmacology ; Bacterial Proteins - genetics ; Bacterial Proteins - physiology ; Ciprofloxacin - pharmacology ; DNA Breaks, Double-Stranded ; DNA Helicases - genetics ; DNA Helicases - physiology ; DNA Repair ; DNA Replication ; DNA, Bacterial - genetics ; DNA, Bacterial - metabolism ; Drug Resistance, Multiple, Bacterial - genetics ; Escherichia coli - drug effects ; Escherichia coli - genetics ; Escherichia coli - isolation &amp; purification ; Escherichia coli - metabolism ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - microbiology ; Escherichia coli Proteins - genetics ; Escherichia coli Proteins - physiology ; Exodeoxyribonuclease V - genetics ; Exodeoxyribonuclease V - physiology ; Genes, Bacterial ; Humans ; Microbial Sensitivity Tests ; Molecular Targeted Therapy ; Nalidixic Acid - pharmacology ; Norfloxacin - pharmacology ; Quinolones - pharmacology ; Rec A Recombinases - genetics ; Rec A Recombinases - physiology ; Recombinational DNA Repair ; Serine Endopeptidases - genetics ; Serine Endopeptidases - physiology ; SOS Response (Genetics)</subject><ispartof>Revista española de quimioterapia, 2015-06, Vol.28 (3), p.139-144</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26032998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>González-Soltero, Rocio</creatorcontrib><creatorcontrib>García-Cañas, Ana</creatorcontrib><creatorcontrib>Mohedano, Rosa B</creatorcontrib><creatorcontrib>Mendoza-Chamizo, Belén</creatorcontrib><creatorcontrib>Botello, Emilia</creatorcontrib><title>Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications</title><title>Revista española de quimioterapia</title><addtitle>Rev Esp Quimioter</addtitle><description>Quinolones are one of the types of antibiotics with higher resistance rates in the last years. At molecular level, quinolones block type II topoisomerases producing double strand breaks (DSBs). These DSBs could play a double role, as inductors of the quinolone bactericidal effects but also as mediators of the resistance and tolerance mechanisms. In this work we have studied the molecular pathways responsible for DSBs repair in the quinolone susceptibility: the stalled replication fork reversal (recombination-dependent) (RFR), the SOS response induction, the translesional DNA synthesis (TLS) and the nucleotide excision repair mechanisms (NER). For this reason, at the European University in Madrid, we analysed the minimal inhibitory concentration (MIC) to three different quinolones in Escherichia coli mutant strains coming from different type culture collections. recA, recBC, priA and lexA mutants showed a significant reduction on the MIC values for all quinolones tested. No significant changes were observed on mutant strains for TLS and NER. These data indicate that in the presence of quinolones, RFR mechanisms and the SOS response could be involved in the quinolone susceptibility.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Bacterial Proteins - genetics</subject><subject>Bacterial Proteins - physiology</subject><subject>Ciprofloxacin - pharmacology</subject><subject>DNA Breaks, Double-Stranded</subject><subject>DNA Helicases - genetics</subject><subject>DNA Helicases - physiology</subject><subject>DNA Repair</subject><subject>DNA Replication</subject><subject>DNA, Bacterial - genetics</subject><subject>DNA, Bacterial - metabolism</subject><subject>Drug Resistance, Multiple, Bacterial - genetics</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - isolation &amp; purification</subject><subject>Escherichia coli - metabolism</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Escherichia coli Proteins - genetics</subject><subject>Escherichia coli Proteins - physiology</subject><subject>Exodeoxyribonuclease V - genetics</subject><subject>Exodeoxyribonuclease V - physiology</subject><subject>Genes, Bacterial</subject><subject>Humans</subject><subject>Microbial Sensitivity Tests</subject><subject>Molecular Targeted Therapy</subject><subject>Nalidixic Acid - pharmacology</subject><subject>Norfloxacin - pharmacology</subject><subject>Quinolones - pharmacology</subject><subject>Rec A Recombinases - genetics</subject><subject>Rec A Recombinases - physiology</subject><subject>Recombinational DNA Repair</subject><subject>Serine Endopeptidases - genetics</subject><subject>Serine Endopeptidases - physiology</subject><subject>SOS Response (Genetics)</subject><issn>1988-9518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kFtLAzEUhIMgtlb_guTRl4Vkb018K7VeoCiIPi9nc6FHs8k2yQr99y6oTzMDH8MwZ2TJpRCFbLhYkMuUPhmrq1ryC7IoW1aVUool8W_BGRos1WHqZ5dyBK_p_cuG9tHAF41mBIzUhkiPE_rggp8p4xNm_MZ8oujpLqmDiagOCFQFh3c0zxlGM2VUFIfRoYKMwacrcm7BJXP9pyvy8bB73z4V-9fH5-1mX4y85rmwvLdczBtZUypjBYfaSqk4MCFbK0pZ6xq4FYbBWqqy0lJL3trKgtZaNlCtyO1v7xjDcTIpdwMmZZwDb8KUOt6KZt0y3jYzevOHTv1gdDdGHCCeuv-Pqh-IfGPK</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>González-Soltero, Rocio</creator><creator>García-Cañas, Ana</creator><creator>Mohedano, Rosa B</creator><creator>Mendoza-Chamizo, Belén</creator><creator>Botello, Emilia</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201506</creationdate><title>Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications</title><author>González-Soltero, Rocio ; García-Cañas, Ana ; Mohedano, Rosa B ; Mendoza-Chamizo, Belén ; Botello, Emilia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-f1bf18032052cef81a4f99c1a0896f8294d4a1f8e0a79c23d9d916f3faddd95a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2015</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Bacterial Proteins - genetics</topic><topic>Bacterial Proteins - physiology</topic><topic>Ciprofloxacin - pharmacology</topic><topic>DNA Breaks, Double-Stranded</topic><topic>DNA Helicases - genetics</topic><topic>DNA Helicases - physiology</topic><topic>DNA Repair</topic><topic>DNA Replication</topic><topic>DNA, Bacterial - genetics</topic><topic>DNA, Bacterial - metabolism</topic><topic>Drug Resistance, Multiple, Bacterial - genetics</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - isolation &amp; purification</topic><topic>Escherichia coli - metabolism</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Escherichia coli Proteins - genetics</topic><topic>Escherichia coli Proteins - physiology</topic><topic>Exodeoxyribonuclease V - genetics</topic><topic>Exodeoxyribonuclease V - physiology</topic><topic>Genes, Bacterial</topic><topic>Humans</topic><topic>Microbial Sensitivity Tests</topic><topic>Molecular Targeted Therapy</topic><topic>Nalidixic Acid - pharmacology</topic><topic>Norfloxacin - pharmacology</topic><topic>Quinolones - pharmacology</topic><topic>Rec A Recombinases - genetics</topic><topic>Rec A Recombinases - physiology</topic><topic>Recombinational DNA Repair</topic><topic>Serine Endopeptidases - genetics</topic><topic>Serine Endopeptidases - physiology</topic><topic>SOS Response (Genetics)</topic><toplevel>online_resources</toplevel><creatorcontrib>González-Soltero, Rocio</creatorcontrib><creatorcontrib>García-Cañas, Ana</creatorcontrib><creatorcontrib>Mohedano, Rosa B</creatorcontrib><creatorcontrib>Mendoza-Chamizo, Belén</creatorcontrib><creatorcontrib>Botello, Emilia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revista española de quimioterapia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>González-Soltero, Rocio</au><au>García-Cañas, Ana</au><au>Mohedano, Rosa B</au><au>Mendoza-Chamizo, Belén</au><au>Botello, Emilia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications</atitle><jtitle>Revista española de quimioterapia</jtitle><addtitle>Rev Esp Quimioter</addtitle><date>2015-06</date><risdate>2015</risdate><volume>28</volume><issue>3</issue><spage>139</spage><epage>144</epage><pages>139-144</pages><eissn>1988-9518</eissn><abstract>Quinolones are one of the types of antibiotics with higher resistance rates in the last years. At molecular level, quinolones block type II topoisomerases producing double strand breaks (DSBs). These DSBs could play a double role, as inductors of the quinolone bactericidal effects but also as mediators of the resistance and tolerance mechanisms. In this work we have studied the molecular pathways responsible for DSBs repair in the quinolone susceptibility: the stalled replication fork reversal (recombination-dependent) (RFR), the SOS response induction, the translesional DNA synthesis (TLS) and the nucleotide excision repair mechanisms (NER). For this reason, at the European University in Madrid, we analysed the minimal inhibitory concentration (MIC) to three different quinolones in Escherichia coli mutant strains coming from different type culture collections. recA, recBC, priA and lexA mutants showed a significant reduction on the MIC values for all quinolones tested. No significant changes were observed on mutant strains for TLS and NER. These data indicate that in the presence of quinolones, RFR mechanisms and the SOS response could be involved in the quinolone susceptibility.</abstract><cop>Spain</cop><pmid>26032998</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1988-9518
ispartof Revista española de quimioterapia, 2015-06, Vol.28 (3), p.139-144
issn 1988-9518
language spa
recordid cdi_proquest_miscellaneous_1685760165
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Anti-Bacterial Agents - pharmacology
Bacterial Proteins - genetics
Bacterial Proteins - physiology
Ciprofloxacin - pharmacology
DNA Breaks, Double-Stranded
DNA Helicases - genetics
DNA Helicases - physiology
DNA Repair
DNA Replication
DNA, Bacterial - genetics
DNA, Bacterial - metabolism
Drug Resistance, Multiple, Bacterial - genetics
Escherichia coli - drug effects
Escherichia coli - genetics
Escherichia coli - isolation & purification
Escherichia coli - metabolism
Escherichia coli Infections - drug therapy
Escherichia coli Infections - microbiology
Escherichia coli Proteins - genetics
Escherichia coli Proteins - physiology
Exodeoxyribonuclease V - genetics
Exodeoxyribonuclease V - physiology
Genes, Bacterial
Humans
Microbial Sensitivity Tests
Molecular Targeted Therapy
Nalidixic Acid - pharmacology
Norfloxacin - pharmacology
Quinolones - pharmacology
Rec A Recombinases - genetics
Rec A Recombinases - physiology
Recombinational DNA Repair
Serine Endopeptidases - genetics
Serine Endopeptidases - physiology
SOS Response (Genetics)
title Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A56%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20double%20strand%20DNA%20break%20repair%20for%20quinolone%20sensitivity%20in%20Escherichia%20coli:%20therapeutic%20implications&rft.jtitle=Revista%20espa%C3%B1ola%20de%20quimioterapia&rft.au=Gonz%C3%A1lez-Soltero,%20Rocio&rft.date=2015-06&rft.volume=28&rft.issue=3&rft.spage=139&rft.epage=144&rft.pages=139-144&rft.eissn=1988-9518&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1685760165%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1685760165&rft_id=info:pmid/26032998&rfr_iscdi=true